Interventions comprised placebo or recombinant GH injections three times a week , with daily oral placebo or oral EE@ during childhood ( @ ng/kg/d , ages @-@ y ; @ ng/kg/d , ages > @-@ y ) ; after age @ , all patients received escalating EE@ starting at a nominal dosage of @ ng/kg/d .